Dihydralazine sulfate 50 mg | Purity Not Available
TargetMol
Dihydralazine sulfate
Search Results
Piribedil 100 mg | Purity Not Available
TargetMol
Piribedil is a dopamine D2 agonist, used in the treatment of Parkinson’s disease.
More Information Supplier PagePiribedil
Piribedil 50 mg | Purity Not Available
TargetMol
Piribedil is a dopamine D2 agonist, used in the treatment of Parkinson’s disease.
More Information Supplier PagePiribedil
AMG-337 100 mg | 99.82%
TargetMol
AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).
More Information Supplier PageAMG-337
Pre-084 10 mg | Purity Not Available
TargetMol
Pre-084
RE-640 5 mg | 99.91%
TargetMol
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
More Information Supplier PageRE-640
RE-640 10 mg | 99.91%
TargetMol
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
More Information Supplier PageRE-640
Fluoroclebopride 50 mg | 99.80%
TargetMol
Fluoroclebopride
AMG-337 10 mg | 99.82%
TargetMol
AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).
More Information Supplier PageAMG-337
AMG-337 25 mg | 99.82%
TargetMol
AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).
More Information Supplier PageAMG-337